Anzeige
Mehr »
Login
Freitag, 10.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J20J | ISIN: US44934S2068 | Ticker-Symbol: HWT1
NASDAQ
10.05.24
21:43 Uhr
1,530 US-Dollar
+0,050
+3,38 %
1-Jahres-Chart
ICAD INC Chart 1 Jahr
5-Tage-Chart
ICAD INC 5-Tage-Chart

Aktuelle News zur ICAD Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
02.05.iCAD, Inc.: iCAD to Report First Quarter 2024 Financial Results on May 15, 20242
11.04.iCAD, Inc.: iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium1
09.04.iCAD, Inc.: iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation1
08.04.iCAD, Inc.: iCAD's ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting876NASHUA, N.H., April 08, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today that new data indicates its...
► Artikel lesen
02.04.iCAD, Inc.: iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale1
13.03.Earnings call: iCAD reports growth in AI cancer detection market2
12.03.icad: Q4 Earnings Insights1
12.03.iCAD Non-GAAP EPS of -$0.02 beats by $0.03, revenue of $4.74M beats by $0.46M1
12.03.iCAD, Inc.: iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results306Annual Recurring Revenue of $8.7 million, an increase of 15% year-over-yearFull-Year Operating Cash Flow ($5) million vs. ($12.8) million prior yearYear ending cash balance of $21.7M NASHUA, N.H....
► Artikel lesen
28.02.iCAD's AI shows promise in breast cancer detection2
28.02.iCAD, Inc.: iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings2
27.02.iCAD, Inc.: iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD1
27.02.iCAD, Inc.: iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 20242
28.11.23iCAD shares rally 15% amid GE Healthcare AI integration update6
28.11.23iCAD, Inc.: iCAD's AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare473Key apps from the iCAD Breast Health Suite are now integrated with GE HealthCare's new MyBreastAI Suite*AI applications streamline workflow and support clinicians in delivering more personalized breast...
► Artikel lesen
27.11.23iCad AI tech accurately predicts breast cancer risk, provides heart disease insights2
27.11.23iCAD, Inc.: iCAD's ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease287New research presented at Radiological Society of North America annual meeting confirms ability of ProFound Breast Health Suite to predict a woman's one to two-year risk for breast canceriCAD...
► Artikel lesen
14.11.23iCAD, Inc. (ICAD) Q3 2023 Earnings Call Transcript1
14.11.23iCAD, Inc.: iCAD to Participate in the 14th Annual Craig-Hallum Alpha Select Conference1
14.11.23Earnings call: iCAD reports Q3 2023 results, divests Xoft subsidiary, and focuses on ProFound AI Breast Health business1
Seite:  Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1